ISLAA Highlights 2013

Topics and Speakers

Embryology, Anatomy, and Histopathology of Left Atrial Appendage

Samuel Asirvatham, M.D.Mayo Clinic, Rochester, Minnesota

Physiologic Contributions of the LAA on Systemic Homeostasis

Dhanunjaya Lakkireddy, M.D.University of Kansas Hospital, Kansas City, Kansas

Systemic Thromboembolism and the Role of LAA

Luigi DiBiase, M.D.Albert Einstein College of Medicine at Montfiore Hospital, New York, New York

Role of LAA in Atrial Arrhtyhmias Origin and Maintenance/ Role of LAA Isolation in AF Treatment

Andrea Natale, M.D.Texas Cardiac Arrhythmia Institute, Austin, Texas

Risk Assessment Tools for Stroke Prophylaxis and Bleeding

Loren Berenbom, M.D.University of Kansas Hospital, Kansas City, Kansas

How do you Balance Anticoagulation and Bleeding in High-Risk Patients?

Peter Tadros, M.D.University of Kansas Hospital, Kansas City, Kansas

Debate: Everyone with a CHADS2 Score of 2 or More Should be considered for LAA Closure/Ligation

Matthew Price, M.D.Scripps Clinic Torrey Pines, La Jolla, California

Brian Whisenant, M.D. Intermountain Heart Institute, Murray, Utah

Essentials of Transseptal Puncture as is Relevant to LAA Closure or Ligation

Vijay Swarup, M.D.Arizona Heart Rhythm Institute, Phoenix, Arizona

Dry Pericardial Access: Rules of Engagement

Randall Lee, M.D.University California San Francisco, San Francisco, California

Patient Selection: Who is a Good Candidate for LAA Exclusion?

Matthew Price, M.D.Scripps Clinic Torrey Pines, La Jolla, California

Evolution of Percutaneous Techniques in LAA Occlusion or Exclusion

Zoltan Turi, M.D.Cooper University, Cherry Hill, New Jersey

Past, Present and Future of Surgical Left Atrial Appendage Exclusion

Mark Gillinov, M.D.Cleveland Clinic, Cleveland, Ohio

Is LAA Occlusion/Exclusion Good Enough to Allow for Discontinuation of Coumadin in Patients with AF and Higher Risk

Debate:

Ted Feldman, M.D.Evanston Hospital, Evanston, Illinois

Samuel Asirvatham, M.D.Mayo Clinic, Rochester, Minnesota

How to Set up a LAA Exclusion Program

Vijay Swarup, M.D. – Arizona Heart Rhythm Institute, Phoenix, Arizona

Transoesophageal Echo in LAA Exclusion

Swaminatha Gurudevan, M.D.Cedars-Sinai Heart Institute, Los Angeles, CA

Role of CT imaging in Left Atrial Appendage Exclusion

Swaminatha Gurudevan, M.D.Cedars-Sinai Heart Institute, Los Angeles, CA

Tips and Tricks to Prevent Complincations During LAA Exclusion

Rodney Horton — Texas Cardiac Arrhythmia Institute, Austin, Texas

Managing Complications in LAA Exclusion Procedures — Thrombus, Perforation, Device Embolization, etc.

David L. Holmes Jr., MD — Mayo Clinic, Rochester, Minnesota

Post-Procedural Anticoagulation Management After LAA Exclusion

Ted Feldman, MD — Evanston Hospital, Evanston, Illinois

Debate: Should LAA be Ligated outinely During Open Heart Surgery?

Mike Mack, MD — The Heart Hospital at Baylor, Plano, Texas

Gregory Muehlebach, MD – University of Kansas Hospital, Kansas City, Kansas

Impact of Surgical Ablation or Exclusion of LAA – Implications to Rhythm Control

Richard Whitlock, MD — Population Health Research Institute at McMaster University, Hamilton, Ontario

LAA Ligation as an Adjunctive Therapy for AF Ablation

Dhanunjaya Lakkireddy, MD – University of Kansas Hospital, Kansas City, Kansas

Debate: Who Should Perform LAA Occlusion/Exclusion Procedures

Michael Mack — The Heart Hospital at Baylor, Plano, Texas

Rodney Horton — Texas Cardiac Arrhythmia Institute, Austin, Texas

David R. Holmes Jr. — Mayo Clinic, Rochester, Minnesota

Clinical Trials in LAAA:

Protect AF — David R. Holmes Jr.

Place II Case Study — Randall Lee

Amplatzer Cardiac Plug Study — Saibal Kar

Surgical Study — Michael Mack

LAA Ligation and Occlusion Technology in the Incubator

Andrea Natale — Texas Cardiac Arrhythmia Institute, Austin, Texas

Why should the LAA Exclusion be a Combined EP Interventional Effort?

Matthew Earnest — University of Kansas Hospital, Kansas City, Kansas

Managing Stroke and Bleeding Risk in Patients with AF — Where do Anticoagulation and Exclusion Devices Fit in the Therapeutic Spectrum?

Miguel Valderrabano — Methodist DeBakey Cardiology Associates, Houston, Texas

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Photo Gallery

Videos

Click here to view videos.

 

 

Copyright © ISLAA-KC. All Rights Reserved. Privacy Policy
Site Created by KC Web Specialists, LLC.